Antifungal agents and therapy for infants and children with invasive fungal infections: a pharmacological perspective

Authors


Correspondence

Professor William Hope, Department of Molecular and Clinical Pharmacology, University of Liverpool, Sherrington Building, Ashton Street, Liverpool L69 3GE, UK.

Tel.: +44 (0)151 794 5941

E-mail: william.hope@liverpool.ac.uk

Abstract

Invasive fungal infections, although relatively rare, are life-threatening diseases in premature infants and immunocompromised children. While many advances have been made in antifungal therapeutics in the last two decades, knowledge of the pharmacokinetics and pharmacodynamics of antifungal agents for infants and children remains incomplete. This review summarizes the pharmacology and clinical utility of currently available antifungal agents and discusses the opportunities and challenges for future research.

Ancillary